Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Imaging Cytometer

By Drug Discovery Trends Editor | December 3, 2013

Molecular Devices’ next-generation SpectraMax MiniMax 300 imaging cytometer is designed to enable both cellular visualization and stain-free cell-based analysis on the field-upgradable SpectraMax i3 multi-mode microplate reader.  Brightfield- and fluorescence-based green and red channel cellular image acquisition and analysis is available using the SoftMax Pro software workflow. The combination of cellular imaging with stain-free cell counting and confluency measurements with microplate-based applications is designed to help scientists compress their workflows and increase efficiency.
 
The SpectraMax MiniMax 300 imaging cytometer features the StainFree Cell Detection algorithm, which enables cell confluency and cell counting measurements on an imaging plate reader without the need for destructive stains. With two additional fluorescence detection channels-green and red–researchers may now perform and analyze a wide range of cellular viability and cell toxicity assays, including ratiometric assays such as transfection efficiency. The SpectraMax i3 system offers three integrated detection modes while its flexible design enables a wide array of assay possibilities. The patented user-exchangeable cartridge design expands the system’s detection capabilities with cartridges like the recently launched ScanLater Western blot detection system, which enables protein analysis on a plate reader.  
 
The SpectraMax i3 platform with MiniMax 300 imaging cytometer and ScanLater western blot system are all managed through SoftMax Pro data acquisition and analysis software, recognized industry-wide for its ease of use. With simple to set-up plate reader prompts and predefined analysis features, results are realized and analyzed quickly. The SpectraMax i3 system is also available for use in GMP and GLP labs when used with SoftMax Pro 6 GxP microplate data compliance software.
 
www.moleculardevices.com

Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50